CD274 and breast cancer: The study by Ali et al. (57) is noteworthy because it examined PD-L1 expression in 3,916 BC, finding 6% PD-L1+ immune cells (235/3,916) and 1.7% PD-L1+ tumor cells (66/3,916) by IHC.